Back
Results - Announcements
Sales rise 7.11% to Rs 14.01 crore
Oxygenta Pharmaceutical reports standalone net loss of Rs 2.85 crore in the September 2024 quarter
15-Nov-2024, 07:44
Net Loss of Oxygenta Pharmaceutical reported to Rs 2.85 crore in the quarter ended September 2024 as against net loss of Rs 3.16 crore during the previous quarter ended September 2023. Sales rose 7.11% to Rs 14.01 crore in the quarter ended September 2024 as against Rs 13.08 crore during the previous quarter ended September 2023.
Net Loss of Oxygenta Pharmaceutical reported to Rs 2.85 crore in the quarter ended September 2024 as against net loss of Rs 3.16 crore during the previous quarter ended September 2023. Sales rose 7.11% to Rs 14.01 crore in the quarter ended September 2024 as against Rs 13.08 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended | ||
| Sep. 2024 | Sep. 2023 | % Var. | |
| Sales | 14.01 | 13.08 | 7 |
| OPM % | -15.49 | -15.14 | - |
| PBDT | -2.11 | -2.32 | 9 |
| PBT | -2.77 | -3.15 | 12 |
| NP | -2.85 | -3.16 | 10 |
Powered by Capital Market - Live News